Filiano, Holley and Zhong Receive Funding from Translating Duke Health Initiative for Work in Immunology

Monday, July 15, 2019
Anthony Filiano, PhD; Christopher Holley, MD, PhD; Xiaoping Zhong, MD, PhD

Anthony Filiano, PhD; Christopher Holley, MD, PhD; Xiaoping Zhong, MD, PhD

School of Medicine faculty members Anthony Filiano, PhD; Christopher Holley, MD, PhD; and Xiaoping Zhong, MD, PhD, were selected to receive funding  from the Translating Duke Health Initiative (TDHI) for their research in immunology. Each received $75,000.

 

 

Funded projects:

  • “Fatherly Advice at Conception: A New Memory T cell at the Maternal-Fetal Interface,” Anthony Filiano, PhD, Department of Neurosurgery
  • “Proteomic Profiling of Heart Transplant Donors and Recipients to Determine the Role of Inflammation and Immune Activation in Primary Graft Dysfunctions,” Christopher Holley, MD, PhD, Department of Medicine
  • “Strawberry notch homologue 2 (SBNO2) mutation in common variable immunodeficiency,” Xiaoping Zhong, MD, PhD, Department of Pediatrics

The research projects were selected based on multiple criteria, including overall scientific impact, innovation, and potential for developing new collaborations and funding for translational human immunology.

Immunology is one of five pillars of the Translating Duke Health Initiative, a multi-disciplinary, multi-year commitment to harness the expertise and knowledge found at Duke to address society’s most significant scientific and healthcare challenges. The initiative also funds research focused on Cardiovascular Disease, Brain Metastasis, Brain Resilience, and Children’s Health.